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ducted in the frozen ventricular tissues or in the cultured
cardiomyocytes.
RESULTS SphK2 inhibition signiﬁcantly increased mortality after MI
(Vehicle 20.3% vs. ABC 50.1%). ABC administration obviously exac-
erbated cardiac dysfunction, interstitial ﬁbrosis, and myocardial
apoptosis following MI. SphK2 inhibition upregulated the expression
of remodeling marker genes (ANP, BNP, and b-MHC) in the myocar-
dium. Higher plasma BNP levels in ABC-treated mice indicated more
severe heart failure progression. Compared with vehicle-treated mice,
myocardial HDAC activities were elevated in ABC-treated group. In
the cultured cardiomyocytes, b1 adrenergic receptor agonist-induced
apoptosis and remodeling genes expression were aggravated by
SphK2 knockdown or ABC treatment in the cardiomyocytes, which
was blocked by HDAC inhibitors.
CONCLUSIONS SphK2 and its product S1P exert protective roles in the
remodeling processes and heart failure progression after MI poten-
tially by inhibiting myocardial HDAC activation.
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OBJECTIVES Acute myocardial infarction (AMI) is one of the most
serious diseases that threaten human’s health. AMI may lead to
myocardiolysis, reconstruction and even heart failure. Many experi-
ments demonstrated the potentiality of cardiac stem cells (CSCs) to
treat AMI. They found evidence for enhanced revascularization of the
infarct zone in stem cells-transplanted hearts, and even differentiate
into functional myocytes. A variety of surface markers have been used
to deﬁne CSCs. Until now, we do not virtually know the uniﬁed and
speciﬁc surface markers of CSCs. Recently, the intergrin aV (CD51þ)
are found to express on testicle and myocardial cells. They can pro-
liferate and differentiate into cardiomyocytes and endothelial cells.
The aim of this study was to investigate the effects of CD51 positive
cardiac cells on left ventricular dysfunction or heart failure after AMI.
METHODS CD51 positive cardiac cells were isolated from 7days old
C57BL/6 mice. The cells were labeled by transfected with red ﬂuo-
rescent protein(RFP) before transplant. Wild- type C57BL/6 mice un-
derwent myocardial infarction by ligating the left anterior descending
coronary artery with injection of saline (n¼7), or RFP-CD51þ cardiac
cells (n¼7). Cardiac function was monitored using echocardiography
after 1 week and 4 weeks. The hearts were harvested and frozen at 4w
after cell implantation. Myocardial tissue sections were traced and
stained with immunoﬂuorescence to ﬁnd cells which glowing red
ﬂuorescent and alpha sarcomeric actin positive under ﬂuorescence
microscope.
RESULTS Transplantation of CD51 positive cardiac cells into AMI
mouse hearts improved cardiac function and remodeling, as deter-
mined by echocardiography. Compare with the control group, there
were higher left ventricular ejection fraction (35.9312.09% VS
16.591.88%, p<0.001), shorten fraction (17.306.35% VS 7.510.81%,
p<0.001) and smaller left ventricular end-diastolic volume
(59.7330.84ul VS 118.1641.37ul, p<0.05) in the experimental group
by 1w. The cell treatment group remained signiﬁcantly improved rela-
tive to saline control animals at 4w. The immunoﬂuorescence detection
of cell treatment group showed RFP-CD51þ cells are alpha sarcomeric
actin positive which indicate the transplantation cells can survive in
myocardial infarction regions and differentiate intomature cardiocyte.
CONCLUSIONS The intramyocardial delivery of CD51 positive cardiac
cells after AMI can improve cardiac function, and attenuate remod-
eling at all time points. The in vivo differentiated CD51 positive cells
expressed cardiac markers, as determined by immunohistochemisty.
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OBJECTIVES The objective of this study was to compare the expres-
sion of matrix metalloproteinase-2 (MMP-2) and mitogen-activatedprotein kinases (MAPKs) pathway molecules in ascending thoracic
aortic aneurysms (ATAAs) of patients with bicuspid and tricuspid
aortic valves.
METHODS Ascending aortic aneurysmal wall specimens and valve
samples were taken from tricuspid aortic valves (TAV) patients (n¼20,
51.57.6 years) and tricuspid aortic valves(BAV)patients (n¼20,
47.46.3 years) when surgery repair. Normal ascending aortic speci-
mens (n¼20) were obtained from 20 patients with coronary heart
diseases (CHD) undergoing CABG without aortopathy. MMP-2
expression was examined by qPCR, Western blot in aortic and valve
tissues. MAPKs were measured by Western blot in aortic and valvular
specimens. Some aneurysmal walls were stained with HE and EVG.
RESULTS By histological examination all aortic aneurysm walls
showed TAV aneurysms patients exhibited severe elastin fragmenta-
tion and markedly decreased elastin and much collagen deposition,
compared with BAV aneurysms. Aortas from the BAV group displayed
intact and regular arrayed elastic ﬁbers in the intima and media and
very few collagens. MMP-2 expression was greater in valves and aortic
aneurysm tissues from ATAAs associated with bicuspid valves when
compared with those from tricuspid valves, irrespective of the level of
mRNA and protein (p<0.05). In the aneurysmal wall specimens, t-p38
MAPK was higher in TAV patients than that in BAV patients and CHD
patients (p<0.05). The p-p38 level was also increased in TAV aneu-
rysmal aortic walls compared with BAV group. However, there is no
signiﬁcant difference in t-p38 MAPK between BAV patients and CHD
patients (p>0.05). In addition, t-p38 and p-p38 MAPK levels had also
no signiﬁcant differences between BAV and CHD patients. Addition-
ally, No statistical differences were found in p-ERK1/2, t-ERK1/2 and
p-ERK/t-ERK1/2 between these three groups. Compared with normal
aortic group, p-JNK, t-JNK and p-JNK/t-JNK were increased in two
aneurysmal groups associated with BAV and TAV (p<0.05). Addi-
tionally, the BAV patients have increased levels of t-p54JNK and
p-p54JNK compared with TAV patients. In the valvular tissues, p-p38,
t-p38 and p-p38/t-p38 MAPK were no signiﬁcant differences between
BAV and TAV patients. Additionally, t-ERK1/2 level was higher in TAV
patient than in BAV patient while p-ERK1/2 and p-ERK/t-ERK1/2 levels
had no statistical differences between TAV and BAV patients.
Compared with BAV patients, the levels of p-JNK, t-JNK and p-JNK/t-
JNK were increased in TAV patients (p<0.05).
CONCLUSIONS The up-regulation of MMP-2 in aneurysms associated
with BAV may partly elucidate the predilection to aneurysm forma-
tion in these patients compared with TAV. Furthermore, in the BAV
associated with ascending aortic aneurysms, increased p54JNK level
was found, which may contribute to elucidate the elevated level of
MMP-2 compared with TAV associated with ascending aortic aneur-
ysms.
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OBJECTIVES Nerve growth factor (NGF) is one of the most important
bioactive molecules in nervous system, which involved in neuronal
differentiation, development, repair and adjusting their general
functions. Current studies have demonstrated that NGF plays a pro-
tective role in myocardial infarction and early reperfusion by reducing
the myocardial cell apoptosis and improving ventricular remodeling.
In the study, we investigated the role of nerve growth factor on late
reperfusion by detecting cardiac structure and function with
echocardiography.
METHODS Rats were randomly divided into four groups: Adenoviral
vector group (Adv group, intramyocardial injection, adenoviral vector
10ml in total), NGF overexpression group (NGF group, constructing the
adenovirus vector Ad-NGF containing nerve growth factor gene, 10ul
Ad-NGF as previously described). Sham group and LR group (10ml
normal saline as previously described, respectively). The models of
late reperfusion (LR group, Adv group, NGF group) were established
by ligating the anterior descending branch of coronary artery in
anaesthetized rats, then loosening the ligature after 2 hours, and
starting to reperfusion, the Sham group underwent thoracotomy
without coronary ligation. On the 3th, 7th, 14th and 28th day after
operation, 5 rats in each group were sacriﬁced and their hearts were
harvested. The expression of NGF protein was examined with
immunohistochemisty technology, cardiac structure and function
were measured with echocardiography.
